title: Bayer pulls cerivastatin (Baycol) from market.
authors.forename: E
authors.initials: E
authors.lastname: Wooltorton
mesh_terms: D002170:Canada; D004345:Drug Industry; D004347:Drug Interactions; D015248:Gemfibrozil / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil